Zhu-Ming Zhang1, Pentti M Rautaharju2, Ronald J Prineas2, Laura Loehr3, Wayne Rosamond3, Elsayed Z Soliman4. 1. Epidemiological Cardiology Research Center (EPICARE), Division of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina. Electronic address: zmzhang@wakehealth.edu. 2. Epidemiological Cardiology Research Center (EPICARE), Division of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina. 3. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina. 4. Epidemiological Cardiology Research Center (EPICARE), Division of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina; Department of Internal Medicine, Section of Cardiology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Abstract
BACKGROUND: We evaluated the risk of incident heart failure (HF) associated with various categories of ventricular conduction defects (VCDs) and examined the impact of QRS duration on the risk of HF. METHODS AND RESULTS: This analysis included 14,478 participants from the Atherosclerosis Risk in Communities (ARIC) study who were free of HF at baseline. VCDs (n = 377) were categorized into right and left bundle branch blocks (RBBB and LBBB, respectively), bifascicular BBB (RBBB with fascicular block), indeterminate-type VCD (IVCD), and pooled VCD group excluding lone RBBB. During an average of 18 years' follow-up, 1,772 participants were hospitalized for incident HF. Compared with no VCD, LBBB and pooled VCD were strongly associated with increased risk of incident HF (multivariable hazard ratios 2.87 and 2.29, respectively). Compared with no VCD with QRS duration <100 ms, HF risk was 1.17-fold for the no VCD group with QRS duration 100-119 ms, 1.97-fold for the pooled VCD group with QRS duration 120-139 ms, and 3.25-fold for the pooled VCD group with QRS duration ≥140 ms. HF risk for the pooled VCD group remained significant (1.74-fold for QRS duration 120-139 ms and 2.81-fold for QRS duration ≥140 ms) in the subgroup free from cardiovascular disease at baseline. Lone RBBB was not associated with incident HF. CONCLUSIONS: VCDs except for isolated RBBB are strong predictors of incident HF, and HF risk is further increased as the QRS duration is prolonged >140 ms.
BACKGROUND: We evaluated the risk of incident heart failure (HF) associated with various categories of ventricular conduction defects (VCDs) and examined the impact of QRS duration on the risk of HF. METHODS AND RESULTS: This analysis included 14,478 participants from the Atherosclerosis Risk in Communities (ARIC) study who were free of HF at baseline. VCDs (n = 377) were categorized into right and left bundle branch blocks (RBBB and LBBB, respectively), bifascicular BBB (RBBB with fascicular block), indeterminate-type VCD (IVCD), and pooled VCD group excluding lone RBBB. During an average of 18 years' follow-up, 1,772 participants were hospitalized for incident HF. Compared with no VCD, LBBB and pooled VCD were strongly associated with increased risk of incident HF (multivariable hazard ratios 2.87 and 2.29, respectively). Compared with no VCD with QRS duration <100 ms, HF risk was 1.17-fold for the no VCD group with QRS duration 100-119 ms, 1.97-fold for the pooled VCD group with QRS duration 120-139 ms, and 3.25-fold for the pooled VCD group with QRS duration ≥140 ms. HF risk for the pooled VCD group remained significant (1.74-fold for QRS duration 120-139 ms and 2.81-fold for QRS duration ≥140 ms) in the subgroup free from cardiovascular disease at baseline. Lone RBBB was not associated with incident HF. CONCLUSIONS: VCDs except for isolated RBBB are strong predictors of incident HF, and HF risk is further increased as the QRS duration is prolonged >140 ms.
Authors: Cheuk-Kit Wong; Wanzhen Gao; Ralph A H Stewart; Niels van Pelt; John K French; Philip E G Aylward; Harvey D White Journal: Circulation Date: 2006-08-14 Impact factor: 29.690
Authors: Michael R Gold; Christophe Thébault; Cecilia Linde; William T Abraham; Bart Gerritse; Stefano Ghio; Martin St John Sutton; Jean-Claude Daubert Journal: Circulation Date: 2012-07-10 Impact factor: 29.690
Authors: Robbert Zusterzeel; Kimberly A Selzman; William E Sanders; Daniel A Caños; Kathryn M O'Callaghan; Jamie L Carpenter; Ileana L Piña; David G Strauss Journal: JAMA Intern Med Date: 2014-08 Impact factor: 21.873
Authors: Pentti M Rautaharju; Ron J Prineas; Joy Wood; Zhu-Ming Zhang; Richard Crow; Gerardo Heiss Journal: Am J Cardiol Date: 2007-08-22 Impact factor: 2.778
Authors: Zhu-ming Zhang; Pentti M Rautaharju; Elsayed Z Soliman; Joann E Manson; Lisa W Martin; Marco Perez; Mara Vitolins; Ronald J Prineas Journal: Circ Heart Fail Date: 2013-05-31 Impact factor: 8.790
Authors: Leonard Ilkhanoff; Kiang Liu; Hongyan Ning; Saman Nazarian; David A Bluemke; Elsayed Z Soliman; Donald M Lloyd-Jones Journal: Eur J Heart Fail Date: 2012-07-12 Impact factor: 15.534
Authors: Nikhil Patel; Wesley T O'Neal; S Patrick Whalen; Elsayed Z Soliman Journal: Ann Noninvasive Electrocardiol Date: 2017-06-29 Impact factor: 1.468
Authors: Wesley T O'Neal; Waqas T Qureshi; Saman Nazarian; Nadine Kawel-Boehm; David A Bluemke; Joao A C Lima; Elsayed Z Soliman Journal: Clin Cardiol Date: 2016-08-23 Impact factor: 2.882
Authors: Wesley T O'Neal; Matylda Mazur; Alain G Bertoni; David A Bluemke; Mouaz H Al-Mallah; Joao A C Lima; Dalane Kitzman; Elsayed Z Soliman Journal: J Am Heart Assoc Date: 2017-05-25 Impact factor: 5.501
Authors: Heli Tolppanen; Krista Siirila-Waris; Veli-Pekka Harjola; David Marono; Jiri Parenica; Philipp Kreutzinger; Tuomo Nieminen; Marie Pavlusova; Tuukka Tarvasmaki; Raphael Twerenbold; Jukka Tolonen; Roman Miklik; Markku S Nieminen; Jindrich Spinar; Christian Mueller; Johan Lassus Journal: ESC Heart Fail Date: 2015-10-30
Authors: Marc Meller Søndergaard; Johannes Riis; Karoline Willum Bodker; Steen Møller Hansen; Jesper Nielsen; Claus Graff; Adrian Holger Pietersen; Jonas Bille Nielsen; Bhupendar Tayal; Christoffer Polcwiartek; Christian Torp-Pedersen; Peter Soegaard; Kristian Hay Kragholm Journal: Open Heart Date: 2021-02
Authors: M Scott Binder; Ricardo H Roda; Andrea M Corse; Sunjeet Sidhu; Sarah Stewart; Andreas S Barth Journal: Ann Clin Transl Neurol Date: 2021-02-27 Impact factor: 4.511
Authors: Oguz Akbilgic; Liam Butler; Ibrahim Karabayir; Patricia P Chang; Dalane W Kitzman; Alvaro Alonso; Lin Y Chen; Elsayed Z Soliman Journal: Eur Heart J Digit Health Date: 2021-10-09